IP Library › Granted Patent US 12,239,694
Granted Patent B2
US 12,239,694 · App. 18/215,276 · Granted Mar 4, 2025

Methods and compositions for improved cognition

Inventor: Dena Dubal (Oakland, CA)
Assignee: The Regents of the University of California
A61K38/47A61P25/28C12N9/2402C12Y302/01031A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,694
App. No.
18/215,276
Granted
Mar 4, 2025
Kind
B2
Abstract

Provided herein are klotho polypeptide compositions and methods for improving cognitive function in an individual comprising treatment of with klotho polypeptides.

Claims (13)

1. A method for improving cognitive function in an individual in need thereof, comprising administering systemically or peripherally to the individual an effective amount of a polypeptide that includes an amino acid sequence that is at least 95% identical to the sequence of the KL1 domain contained in SEQ ID NO: 1, with the proviso that the polypeptide is not a fibroblast growth factor (FGF) fusion protein.

2. The method of claim 1 , wherein the polypeptide further includes an amino acid sequence that is at least 95% identical to the sequence of the KL2 domain contained in SEQ ID NO: 1.

3. The method of claim 1 , further comprising testing the cognitive function of the individual after administering the polypeptide.

4. The method of claim 1 , which improves motor function in the individual.

5. The method of claim 1 , wherein the polypeptide is a fusion protein that also includes a sequence of up to 100 additional amino acids.

6. The method of claim 1 , wherein the polypeptide has beta-glucuronidase activity.

7. The method of claim 1 , wherein the polypeptide binds or promotes activity of FGF23.

8. The method of claim 1 , wherein the polypeptide results in induction of c-fos or increased expression of GluN2B.

9. The method of claim 1 , wherein the polypeptide suppresses wnt signaling, insulin signaling, or transforming growth factor beta-1 (TGF-β1) activity.

10. The method of claim 1 , wherein the polypeptide is administered intravenously or subcutaneously.

11. The method of claim 1 , wherein the individual has normal cognitive function prior to administration of the polypeptide.

12. A method for improving cognitive function in an individual in need thereof, comprising administering systemically or peripherally to the individual an effective amount of a polypeptide that comprises a klotho KL1 domain, wherein the KL1 domain includes the beta-glucosidase/6-phospho-beta-glucosidase/beta-galactosidase motif that resides between amino acids 62-497 of SEQ ID NO: 1, with the proviso that the polypeptide is not an FGF fusion protein.

13. A method for improving cognitive function in an individual in need thereof, comprising administering systemically or peripherally to the individual an effective amount of a polypeptide that comprises a klotho KL1 domain, wherein the KL1 domain has at least one and up to 5% altered, inserted or deleted amino acids compared with the amino acid sequence of the KL1 domain in SEQ ID NO: 1, with the proviso that the polypeptide is not an FGF fusion protein.

Continuity (5)
Continuation 17095673 · Nov 11, 2020
Continuation 16751108 · Jan 23, 2020
Continuation 15548306
Provisional Application 62113300 · Feb 6, 2015
Related Publication 20240108698A1 · Apr 4, 2024
References Cited (80)
US 6579850B1 · Nabeshima et al. · 2003 [cited by applicant]
US 8420088B2 · Glass et al. · 2013 [cited by applicant]
US 8481031B2 · Glass et al. · 2013 [cited by applicant]
US 8778887B2 · Breyer et al. · 2014 [cited by applicant]
US 10300117B2 · Dubal · 2019 [cited by applicant]
US 10632180B2 · Dubal · 2020 [cited by applicant]
US 10864256B2 · Dubal · 2020 [cited by applicant]
US 11738070B2 · Dubal · 2023 [cited by applicant]
US 20040101874A1 · Ghosh et al. · 2004 [cited by applicant]
US 20110195077A1 · Glass et al. · 2011 [cited by applicant]
US 20120172314A1 · Koeffler et al. · 2012 [cited by applicant]
US 20180015151A1 · Dubal · 2018 [cited by applicant]
US 20180037623A1 · Guo et al. · 2018 [cited by applicant]
US 20200230214A1 · Dubal · 2020 [cited by applicant]
CN 101711779A · 2010 [cited by applicant]
CN 102725413A · 2012 [cited by applicant]
CN 107405382A · 2017 [cited by applicant]
EP 1374877A1 · 2004 [cited by applicant]
EP 1374887A1 · 2004 [cited by applicant]
EP 2247614B1 · 2014 [cited by applicant]
EP 3253403 · 2017 [cited by applicant]
IN 201717028223A · 2017 [cited by applicant]
JP 2006240990A · 2006 [cited by applicant]
JP 2012184184A · 2012 [cited by applicant]
JP 2018509393A · 2018 [cited by applicant]
WO 2004100976A1 · 2004 [cited by applicant]
WO 2016127097A1 · 2016 [cited by applicant]
WO 2017085317A1 · 2017 [cited by applicant]
“BU Researchers Discover that Klotho is Neuroprotective Against Alzheimer's Disease Toxic Amyloid”, Available Online at: https://www.bu.edu/news/2014/07/28/bu-researchers-discover-that-klotho-is-neuroprotective-against-… [cited by applicant]
“Database WPI Week 201041”, XP002783543 , Thomas Scientific, May 26, 2010, pp. 1-2. [cited by applicant]
“Database WPI Week 201271”, XP002783542, Thomas Scientific, Sep. 27, 2012, pp. 1-2. [cited by applicant]
“Genes and Intelligence The 3% Solution”, The Economist, Available Online at: https://www.economist.com/science-and-technology/2014/05/08/the-3-solution, May 8, 2014, 4 pages. [cited by applicant]
“Klotho Precursor [ [cited by applicant]
Abraham , et al., “Small-Molecule Klotho Enhancers as Novel Treatment of Neurodegeneration”, Future Medicinal Chemistry, vol. 4, No. 13, Sep. 2012, pp. 1671-1679. [cited by applicant]
Arking , et al., “Association of Human Aging with a Functional Variant of Klotho”, Proceedings of the National Academy of Sciences, vol. 99, No. 2, Jan. 22, 2002, pp. 856-861. [cited by applicant]
Banks, “Characteristics of Compounds That Cross The Blood-Brain Barrier”, Proceedings of BMC Neurology; vol. 9, Jun. 12, 2009, 5 pages. [cited by applicant]
Chang, et al., “The Beta-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel”, Science, vol. 310, No. 5747, Oct. 21, 2005, pp. 490-493. [cited by applicant]
Chateau, et al., “Klotho Interferes with a Novel FGF-Signalling Pathway and Insulin/lgf-like Signalling to Improve Longevity and Stress Resistance in Caenorhabditis Elegans”, Aging, vol. 2, No. 9, Sep. 2010, pp. 567-581. [cited by applicant]
Chen, et al., “Identification of Cleavage Sites Leading to the Shed Form of the Anti-Aging Protein Klotho”, Biochemistry, vol. 53, No. 34, Aug. 11, 2014, pp. 5579-5587. [cited by applicant]
Chen, et al., “Inhibition of Lung Cancer Cells Growth, Motility and Induction of Apoptosis by Klotho, a Novel Secreted Wnt Antagonist, in a Dose-Dependent Manner”, Cancer Biology & Therapy, vol. 13, No. 12, Oct. 2012, p… [cited by applicant]
Chen, et al., “Insulin Stimulates the Cleavage and Release of the Extracellular Domain of Klotho by ADAM10 and ADAM17”, PNAS, vol. 104, No. 50, Dec. 11, 2007, pp. 19796-19801. [cited by applicant]
Chen, et al., “The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS”, Journal of Neuroscience, vol. 33, No. 5, Jan. 30, 2013, pp. 1927-1939. [cited by applicant]
Di Bona, et al., “Association of Klotho Polymorphisms with Healthy Aging: A Systematic Review and Meta-Analysis”, Rejuvenation Research, vol. 17, No. 2, Apr. 2014, pp. 212-216. [cited by applicant]
Dubal, et al., “Life Extension Factor Klotho Enhances Cognition”, Cell Reports, vol. 7, No. 4, May 22, 2014, pp. 1065-1076. [cited by applicant]
Dubal, et al., “Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in haPP Transgenic Mice”, Journal of Neuroscience, vol. 35, No. 6, Feb. 11, 2015, pp. 2358-2371. [cited by applicant]
Duce, et al., “Gene Profile Analysis Implicates Klotho as an Important Contributor to Aging Changes in Brain White Matter of the Rhesus Monkey”, Glia, vol. 56, No. 1., Jan. 1, 2008, pp. 106-117. [cited by applicant]
EP16747364.4 , “Extended European Search Report”, Aug. 24, 2018, 11 pages. [cited by applicant]
EP21187176.9, “Extended European Search Report”, Jan. 13, 2022, 13 pages. [cited by applicant]
Fei, et al., “Research Progress of the Association Between Senile Dementia and Klotho Gene”, Journal of Modern Medicine & Health, vol. 38, No. 20, Oct. 30, 2014, pp. 3077-3079. [cited by applicant]
Foster, “Biological Markers of Age-Related Memory Deficits”, CNS Drugs, vol. 20, No. 2, 2006, pp. 153-166. [cited by applicant]
Imura, et al., “Alpha-klotho as a Regulator of Calcium Homeostasis”, Science, vol. 316, No. 5831, Jun. 15, 2007, pp. 1615-1618. [cited by applicant]
Imura, et al., “Secreted Klotho Protein in Sera and CSF: Implication for Post-translational Cleavage in Release of Klotho Protein from Cell Membrane”, FEBS Letters, vol. 565, No. 1-3, Apr. 13, 2004, pp. 143-147. [cited by applicant]
IN201717028223, “First Examination Report”, Feb. 19, 2021, 8 pages. [cited by applicant]
Invidia, et al., “The Frequency of Klotho KL-VS Polymorphism in a Large Italian Population, from Young Subjects to Centenarians, Suggests the Presence of Specific Time Windows for Its Effect”, Biogerontology, vol. 11, N… [cited by applicant]
Kuang, et al., “Klotho Upregulation Contributes to the Neuroprotection of Ligustilide in an Alzheimer's Disease Mouse Model”, Neurobiology of Aging, vol. 35, No. 1, Jan. 2014, pp. 169-178. [cited by applicant]
Kuro-O, et al., “Mutation of the Mouse Klotho Gene Leads to a Syndrome Resembling Ageing”, Nature, vol. 390, No. 6655, Nov. 6, 1997, pp. 45-51. [cited by applicant]
Kurosu, et al., “Suppression of Aging in Mice by the Homnone Klotho”, Science, vol. 309, No. 5742, Sep. 16, 2005, pp. 1829-1833. [cited by applicant]
Lai, et al., “Open and Shut: Crystal Structures of the Dodecylmaltoside Solubilized Mechanosensitive Channel of Small Conductance from [cited by applicant]
Leon, et al., “Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and α-Synuclein Transgenic Mice”, Cell Reports, vol. 20, No. 6, Aug. 8, 2017, pp. 1360-1371. [cited by applicant]
Liu, et al., “Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging”, Science, vol. 317, No. 5839, Aug. 10, 2007, pp. 803-806. [cited by applicant]
Masso, et al., “Secreted aKlotho Isoform Protects Against Age-Dependent Memory Deficits”, Molecular Psychiatry, vol. 23, No. 9, Oct. 31, 2017, pp. 1-11. [cited by applicant]
Matsumura, “Identification of the Human Klotho Gene and its Two Transcripts Encoding Membrane and Secreted Klotho Protein”, Biochemical and Biophysical Research Communications, vol. 242, No. 3, Jan. 26, 1998, pp. 626-62… [cited by applicant]
Mucke, “Neurobiology and Therapeutic Potential of Klotho”, National Institutes of Health, Available Online at: http://grantome.com/grant/NIH/R01-NS088532-01, 2014, 4 pages. [cited by applicant]
Nagai, et al., “Cognition Impairment in the Genetic Model of Aging Klotho Gene Mutant Mice: A Role of Oxidative Stress”, The FASEB Journal, vol. 17, No. 1, Jan. 2003, pp. 50-52. [cited by applicant]
PCT/US2016/016842, “International Preliminary Report on Patentability”, Aug. 17, 2017, 7 pages. [cited by applicant]
PCT/US2016/016842, “International Search Report and Written Opinion”, May 3, 2016, 11 pages. [cited by applicant]
Razzaque, “The FGF23-Kiotho Axis: Endocrine Regulation of Phosphate Homeostasis”, Nature Reviews Endocrinology, vol. 5, No. 11, Nov. 2009, pp. 611-619. [cited by applicant]
Semba, et al., “Klotho in the Cerebrospinal Fluid of Adults with and without Alzheimer's Disease”, Neuroscience Letters, vol. 558, Jan. 13, 2014, pp. 37-40. [cited by applicant]
Semba, et al., “Plasma Klotho and Mortality Risk in Older Community-Dwelling Adults”, The Journals of Gerontology Series A Biological Sciences and Medical Sciences, vol. 66, No. 7, Jul. 2011, pp. 794-800. [cited by applicant]
Shiozaki, et al., “Morphological and Biochemical Signs of Age-Related Neurodegenerative Changes in Klotho Mutant Mice”, Neuroscience, vol. 152, No. 4, Apr. 9, 2008, pp. 924-941. [cited by applicant]
Shiraki-Iida, et al., “Structure of the Mouse Klotho Gene and Its Two Transcripts Encoding Membrane and Secreted Protein”, FEBS Letters, vol. 424, No. 1-2, Mar. 6, 1998, pp. 6-10. [cited by applicant]
Tohyama, et al., “Klotho Is a Novel Beta-Glucuronidase Capable of Hydrolyzing Steroid Beta-Glucuronides”, Journal of Biological Chemistry, vol. 279, No. 11, Mar. 12, 2004, pp. 9777-9784. [cited by applicant]
Toure, et al., “The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein-Protein Interactions”, ACS Medicinal Chemistry Letters, vol. 4, No. 2, Jan. 4, 2013, pp. 186-190. [cited by applicant]
Tucker Zhou, et al., “Biochemical and Functional Characterization of the Klotho-VS Polymorphism Implicated in Aging and Disease Risk”, Journal of Biological Chemistry, vol. 288, No. 51, Dec. 20, 2013, p. 36302-36311. [cited by applicant]
Urakawa, et al., “Klotho Converts Canonical FGF Receptor Into a Specific Receptor for FGF23”, Nature, vol. 444, No. 7120, Dec. 7, 2006, pp. 770-774. [cited by applicant]
Wang, et al., “Current Understanding of Klotho”, Ageing Research Reviews, vol. 8, No. 1, Jan. 2009, pp. 43-51. [cited by applicant]
Xu, et al., “Molecular Basis of Klotho: from Gene to Function in Aging”, Endocrine Reviews, vol. 36, No. 2, Apr. 2015, pp. 174-193. [cited by applicant]
Yokoyama, et al., “Variation in Longevity Gene Klotho Is Associated with Greater Cortical Volumes”, Annals of Clinical and Translational Neurology, vol. 2, No. 3, Mar. 2015, pp. 215-230. [cited by applicant]
Zeldich, et al., “The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System”, Journal of Biological Chemistry, vol. 289, No. 35, Aug. 29, 2014, pp. 24700-24715. [cited by applicant]
Zhou, et al., “Studies on Serum Klotho Protein Concentration and Mild Cognitive Dysfunction”, Chin J. Psychiatry, vol. 47, No. 1, Feb. 2014, pp. 17-20. [cited by applicant]